Nesiritide
- Generic Name
- Nesiritide
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 124584-08-3
- Unique Ingredient Identifier
- P7WI8UL647
- Background
Nesiritide is a medication used to treat acutely decompensated congestive heart failure with dyspnea at rest or with minimal exertion (such as talk, eating or bathing). Nesiritide is a 32 amino acid recombinant human B-type natriuretic peptide.
- Indication
适用于急性代偿性心力衰竭、慢性失代偿性心力衰竭、心肌梗死、心脏导管手术等。由于静脉使用起效快，更适用于急性心力衰竭。
- Associated Conditions
- Acute Decompensated Heart Failure (ADHF)
- Associated Therapies
- -
Nesiritide for Ventilated Congestive Heart Failure
- First Posted Date
- 2020-07-02
- Last Posted Date
- 2020-07-02
- Lead Sponsor
- Shanghai Zhongshan Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT04455477
- Locations
- 🇨🇳
Zhongshan Hospital, Xuhui, Shanghai, China
Early rhBNP on Myocardial Work in Patients With STEMI
- First Posted Date
- 2019-11-08
- Last Posted Date
- 2019-11-08
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT04157868
Early rhBNP on Myocardial Remodeling and Reperfusion in Patients With STEMI
- Conditions
- Interventions
- First Posted Date
- 2019-07-26
- Last Posted Date
- 2023-06-01
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 352
- Registration Number
- NCT04033861
- Locations
- 🇨🇳
Ren Ji Hospital Afflited to School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1
- Conditions
- Interventions
- First Posted Date
- 2018-11-13
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT03738878
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Impact of Nesiritide on Early Postoperative Recovery After Total Cavo-Pulmonary Connection Surgery in Children
- Conditions
- Interventions
- First Posted Date
- 2017-07-02
- Last Posted Date
- 2017-07-06
- Target Recruit Count
- 108
- Registration Number
- NCT03207295
- Locations
- 🇨🇳
Fuwai hospital, Beijing, Beijing, China
Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease
- First Posted Date
- 2016-04-19
- Last Posted Date
- 2019-10-01
- Lead Sponsor
- LI ZHAO
- Target Recruit Count
- 9
- Registration Number
- NCT02742909
- Locations
- 🇨🇳
Shenjing Hospital, Shenyang, Liaoning, China
Natriuretic Peptides and Metabolic Risk in Obesity
- Conditions
- Interventions
- First Posted Date
- 2015-12-30
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Vanderbilt University Medical Center
- Registration Number
- NCT02642523
Nesiritide in Hypertension
- First Posted Date
- 2015-11-20
- Last Posted Date
- 2018-01-03
- Lead Sponsor
- Oslo University Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT02608996
- Locations
- 🇳🇴
Akershus University Hospital, Strømmen, Norway
🇳🇴Oslo University Hospital, Ullevål Hospital, Oslo, Norway
🇳🇴Oslo University Hopital, Rikshospitalet, Oslo, Norway
Testosterone Regulation of the Natriuretic Peptide System
- Conditions
- Interventions
- First Posted Date
- 2014-10-20
- Last Posted Date
- 2017-10-19
- Lead Sponsor
- Massachusetts General Hospital
- Registration Number
- NCT02269072
BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects
- Conditions
- Interventions
- First Posted Date
- 2013-11-07
- Last Posted Date
- 2018-02-14
- Lead Sponsor
- AdventHealth Translational Research Institute
- Target Recruit Count
- 4
- Registration Number
- NCT01977859
- Locations
- 🇺🇸
Translational Research Institute for Metabolism and Diabetes, Orlando, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.